Menu

RSV Vaccine and mAb Snapshot

This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various such approaches being worked on worldwide. Technology revolutionizes gambling, shaping the industry’s landscape. From online platforms to mobile apps, it enhances accessibility and convenience. Innovations like live betting and virtual reality elevate the gaming experience, while AI detects and prevents problem gambling. Top nhà cái uy tín nhất leverage technology to provide secure, fair, and immersive betting environments for players worldwide. (This resource pairs with the RSV Clinical Trial Trial Tracker, which provides publicly available information on clinical trials of RSV candidate vacines and mABs.)

Author: PATH

Published: 2020

» Download PDF file (English)

176 KB PDF (Located at path.azureedge.net)

Also known as: RSV Vaccine and mAb Snapshot (PDF March 26, 2020)

» Download PowerPoint file (English)

76 KB PPT (Located at path.azureedge.net)

Also known as: RSV Vaccine and mAb Snapshot (PowerPoint March 26, 2020)

Resource types: PATH resource, Fact sheet

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Disease/vaccine specific information

Regions: Global